Cargando…
Exosome-Modified Liposomes Targeted Delivery of Thalidomide to Regulate Treg Cells for Antitumor Immunotherapy
Thalidomide (THD), a synthetic derivative of glutamic acid, was initially used as a sedative and antiemetic until the 1960s, when it was found to cause devastating teratogenic effects. However, subsequent studies have clearly demonstrated the anti-inflammatory, anti-angiogenic, and immunomodulatory...
Autores principales: | Yang, Yang, Wang, Qingfu, Zou, Huimin, Chou, Chon-Kit, Chen, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142880/ https://www.ncbi.nlm.nih.gov/pubmed/37111560 http://dx.doi.org/10.3390/pharmaceutics15041074 |
Ejemplares similares
-
Cationic Polymethacrylate-Modified Liposomes Significantly Enhanced Doxorubicin Delivery and Antitumor Activity
por: Wang, Wenxi, et al.
Publicado: (2017) -
Tumor vasculature remolding by thalidomide increases delivery and efficacy of cisplatin
por: Shen, Yanwei, et al.
Publicado: (2019) -
Co-delivery of docetaxel and palmitoyl ascorbate by liposome for enhanced synergistic antitumor efficacy
por: Li, Junxiu, et al.
Publicado: (2016) -
Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma
por: Wei, Minyan, et al.
Publicado: (2015) -
Liposome-Based Drug Delivery Systems in Cancer Immunotherapy
por: Gu, Zili, et al.
Publicado: (2020)